Blog: MIMEDX GROUP, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 7.01 Regulation FD

K. Todd Newton, MiMedx interim Chief Executive Officer, Peter M. Carlson, Chief
Financial Officer, and Matthew Notarianni, Head of Investor Relations, are
expected to attend the Canaccord Genuity MedTech, Diagnostics And Digital
Health & Services Forum on behalf of MiMedx Group, Inc. (the “Company”), on
November 17, 2022. A copy of the presentation materials made available by the
Company in connection with the conference is furnished as Exhibit 99.1 to this
Current Report on Form 8-K (this “Current Report”) and is incorporated herein by
reference.

The information in this Current Report, including Exhibit 99.1, shall not be
deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities
of that section, nor shall such information be deemed incorporated by reference
in any filing under the Securities Act of 1933, as amended, except as expressly
set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit
  No.       Description of Exhibit

99.1          Slide Presentation dated November 17, 2022

104         The cover page from this Current Report on Form 8-K, formatted in
            Inline XBRL.



——————————————————————————–

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s